Published in Am J Epidemiol on August 05, 2008
Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis (2011) 10.96
When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study. Ann Intern Med (2011) 5.35
Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study. Lancet HIV (2015) 4.33
Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions. Curr HIV/AIDS Rep (2010) 3.80
Implementation of G-computation on a simulated data set: demonstration of a causal inference technique. Am J Epidemiol (2011) 3.29
Timing of HAART initiation and clinical outcomes in human immunodeficiency virus type 1 seroconverters. Arch Intern Med (2011) 2.99
Estimating Causal Associations of Fine Particles With Daily Deaths in Boston. Am J Epidemiol (2015) 2.75
Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study. Am J Epidemiol (2010) 2.74
Accounting for bias due to selective attrition: the example of smoking and cognitive decline. Epidemiology (2012) 2.72
Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study. JAMA Neurol (2014) 2.58
The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol (2013) 2.56
When to start treatment? A systematic approach to the comparison of dynamic regimes using observational data. Int J Biostat (2010) 2.50
Changes in glomerular kidney function among HIV-1-uninfected men and women receiving emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis: a randomized clinical trial. JAMA Intern Med (2015) 2.35
Effects of prescription nonsteroidal antiinflammatory drugs on symptoms and disease progression among patients with knee osteoarthritis. Arthritis Rheumatol (2015) 2.34
Invited commentary: positivity in practice. Am J Epidemiol (2010) 2.33
Diagnosing and responding to violations in the positivity assumption. Stat Methods Med Res (2010) 2.29
Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS (2010) 2.23
Diabetes in midlife and cognitive change over 20 years: a cohort study. Ann Intern Med (2014) 2.20
Long term calcium intake and rates of all cause and cardiovascular mortality: community based prospective longitudinal cohort study. BMJ (2013) 2.17
Research priorities for economic analyses of prevention: current issues and future directions. Prev Sci (2014) 2.10
Risk of cardiovascular events associated with current exposure to HIV antiretroviral therapies in a US veteran population. Clin Infect Dis (2015) 2.09
Effects of glucosamine and chondroitin supplementation on knee osteoarthritis: an analysis with marginal structural models. Arthritis Rheumatol (2015) 2.08
Generalizing evidence from randomized clinical trials to target populations: The ACTG 320 trial. Am J Epidemiol (2010) 2.07
Neighborhood poverty and injection cessation in a sample of injection drug users. Am J Epidemiol (2010) 2.07
Effectiveness of patient adherence groups as a model of care for stable patients on antiretroviral therapy in Khayelitsha, Cape Town, South Africa. PLoS One (2013) 2.03
Experimental design and primary data analysis methods for comparing adaptive interventions. Psychol Methods (2012) 2.01
Effect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatment. AIDS (2010) 1.99
Health behaviours, socioeconomic status, and mortality: further analyses of the British Whitehall II and the French GAZEL prospective cohorts. PLoS Med (2011) 1.99
Using marginal structural models to estimate the direct effect of adverse childhood social conditions on onset of heart disease, diabetes, and stroke. Epidemiology (2012) 1.80
Neighborhood Effects in Temporal Perspective. Am Sociol Rev (2011) 1.75
Weight trimming and propensity score weighting. PLoS One (2011) 1.72
Increased dietary sodium is independently associated with greater mortality among prevalent hemodialysis patients. Kidney Int (2012) 1.71
Doubly robust estimation of causal effects. Am J Epidemiol (2011) 1.66
A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIV. Arch Gen Psychiatry (2010) 1.66
An information criterion for marginal structural models. Stat Med (2012) 1.65
Estimating absolute risks in the presence of nonadherence: an application to a follow-up study with baseline randomization. Epidemiology (2010) 1.64
Comparing mortality of peritoneal and hemodialysis patients in the first 2 years of dialysis therapy: a marginal structural model analysis. Clin J Am Soc Nephrol (2013) 1.63
Propensity score methods for confounding control in nonexperimental research. Circ Cardiovasc Qual Outcomes (2013) 1.62
A comparison of methods to estimate the hazard ratio under conditions of time-varying confounding and nonpositivity. Epidemiology (2011) 1.59
Better diet quality and decreased mortality among myocardial infarction survivors. JAMA Intern Med (2013) 1.57
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med (2015) 1.57
Are Early-Life Socioeconomic Conditions Directly Related to Birth Outcomes? Grandmaternal Education, Grandchild Birth Weight, and Associated Bias Analyses. Am J Epidemiol (2015) 1.56
The use of propensity scores to assess the generalizability of results from randomized trials. J R Stat Soc Ser A Stat Soc (2001) 1.56
Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection. AIDS (2010) 1.54
Prescription Opioid Duration, Dose, and Increased Risk of Depression in 3 Large Patient Populations. Ann Fam Med (2016) 1.54
Trends and determinants of survival for over 200 000 patients on antiretroviral treatment in the Botswana National Program: 2002-2013. AIDS (2016) 1.54
Marginal structural models for sufficient cause interactions. Am J Epidemiol (2010) 1.52
A time and place for causal inference methods in perinatal and paediatric epidemiology. Paediatr Perinat Epidemiol (2013) 1.51
Nonexperimental comparative effectiveness research using linked healthcare databases. Epidemiology (2011) 1.50
Observational data for comparative effectiveness research: an emulation of randomised trials of statins and primary prevention of coronary heart disease. Stat Methods Med Res (2011) 1.49
The role of the c-statistic in variable selection for propensity score models. Pharmacoepidemiol Drug Saf (2010) 1.45
Effect of dietary fiber intake on lipoprotein cholesterol levels independent of estradiol in healthy premenopausal women. Am J Epidemiol (2010) 1.44
Endotoxin and gender modify lung function recovery after occupational organic dust exposure: a 30-year study. Occup Environ Med (2015) 1.43
Prescription opioid analgesics increase the risk of depression. J Gen Intern Med (2013) 1.37
Directed Acyclic Graphs for Oral Disease Research. J Dent Res (2016) 1.36
Time scale and adjusted survival curves for marginal structural cox models. Am J Epidemiol (2010) 1.36
Assessing the effect of hormonal contraception on HIV acquisition in observational data: challenges and recommended analytic approaches. AIDS (2013) 1.34
The causal effect of switching to second-line ART in programmes without access to routine viral load monitoring. AIDS (2012) 1.32
Longitudinal study of insulin resistance and sex hormones over the menstrual cycle: the BioCycle Study. J Clin Endocrinol Metab (2010) 1.30
Relationship between renal dysfunction, nephrotoxicity and death among HIV adults on tenofovir. AIDS (2011) 1.28
Joint effects of alcohol consumption and high-risk sexual behavior on HIV seroconversion among men who have sex with men. AIDS (2013) 1.27
Time-modified confounding. Am J Epidemiol (2009) 1.24
A causal framework for understanding the effect of losses to follow-up on epidemiologic analyses in clinic-based cohorts: the case of HIV-infected patients on antiretroviral therapy in Africa. Am J Epidemiol (2012) 1.24
The parametric g-formula for time-to-event data: intuition and a worked example. Epidemiology (2014) 1.22
Gestational exposure to endocrine-disrupting chemicals and reciprocal social, repetitive, and stereotypic behaviors in 4- and 5-year-old children: the HOME study. Environ Health Perspect (2014) 1.18
The relative performance of targeted maximum likelihood estimators. Int J Biostat (2011) 1.17
Negative Control Outcomes and the Analysis of Standardized Mortality Ratios. Epidemiology (2015) 1.16
Analysis of occupational asbestos exposure and lung cancer mortality using the g formula. Am J Epidemiol (2013) 1.15
Iron deficiency and anemia predict mortality in patients with tuberculosis. J Nutr (2011) 1.14
Pregnancy and virologic response to antiretroviral therapy in South Africa. PLoS One (2011) 1.14
Gender differences in mortality and CD4 count response among virally suppressed HIV-positive patients. J Womens Health (Larchmt) (2013) 1.14
From exposures to population interventions: pregnancy and response to HIV therapy. Am J Epidemiol (2014) 1.13
The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study. AIDS (2012) 1.11
Incidence rate of and factors associated with loss to follow-up in a longitudinal cohort of antiretroviral-treated HIV-infected persons: an AIDS Clinical Trials Group (ACTG) Longitudinal Linked Randomized Trials (ALLRT) analysis. HIV Clin Trials (2011) 1.11
Effect of statin use on acute kidney injury risk following coronary artery bypass grafting. Am J Cardiol (2012) 1.10
A marginal structural model analysis for loneliness: implications for intervention trials and clinical practice. J Consult Clin Psychol (2011) 1.09
Current and long-term spousal caregiving and onset of cardiovascular disease. J Epidemiol Community Health (2011) 1.08
Assessing the effect of HIV counselling and testing on HIV acquisition among South African youth. AIDS (2013) 1.08
Propensity scores for confounder adjustment when assessing the effects of medical interventions using nonexperimental study designs. J Intern Med (2014) 1.06
Iron status predicts malaria risk in Malawian preschool children. PLoS One (2012) 1.06
Incident pregnancy and time to death or AIDS among HIV-positive women receiving antiretroviral therapy. PLoS One (2013) 1.05
Selection Bias Due to Loss to Follow Up in Cohort Studies. Epidemiology (2016) 1.04
Assessing mediation using marginal structural models in the presence of confounding and moderation. Psychol Methods (2012) 1.03
Duration and timing of exposure to neighborhood poverty and the risk of adolescent parenthood. Demography (2013) 1.03
Long-term effects of wealth on mortality and self-rated health status. Am J Epidemiol (2010) 1.03
Is cognitive aging predicted by one's own or one's parents' educational level? results from the three-city study. Am J Epidemiol (2012) 1.03
Limitation of inverse probability-of-censoring weights in estimating survival in the presence of strong selection bias. Am J Epidemiol (2011) 1.02
Menstrual bleeding patterns among regularly menstruating women. Am J Epidemiol (2012) 1.02
Statistical approaches for enhancing causal interpretation of the M to Y relation in mediation analysis. Pers Soc Psychol Rev (2014) 1.02
Immediate versus deferred initiation of androgen deprivation therapy in prostate cancer patients with PSA-only relapse. An observational follow-up study. Eur J Cancer (2015) 1.02
Longitudinal structural mixed models for the analysis of surgical trials with noncompliance. Stat Med (2012) 1.00
Antiretroviral therapy reduces the rate of hepatic decompensation among HIV- and hepatitis C virus-coinfected veterans. Clin Infect Dis (2013) 1.00
Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation. Am J Kidney Dis (2015) 0.99
Using marginal structural measurement-error models to estimate the long-term effect of antiretroviral therapy on incident AIDS or death. Am J Epidemiol (2009) 0.98
Evaluation of Selection Bias in an Internet-based Study of Pregnancy Planners. Epidemiology (2016) 0.98
Causal inference in epidemiological studies with strong confounding. Stat Med (2012) 0.98
Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial. Hum Reprod (2014) 0.98
Caffeinated beverage intake and reproductive hormones among premenopausal women in the BioCycle Study. Am J Clin Nutr (2012) 0.98
Marginal structural models and causal inference in epidemiology. Epidemiology (2000) 33.54
A structural approach to selection bias. Epidemiology (2004) 16.44
Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology (2000) 15.40
Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol (2002) 9.76
Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet (2002) 9.66
Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study. Stat Med (1990) 7.00
Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet (2005) 6.60
The consistency statement in causal inference: a definition or an assumption? Epidemiology (2009) 6.36
Quantifying biases in causal models: classical confounding vs collider-stratification bias. Epidemiology (2003) 6.35
Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. Am J Epidemiol (2003) 5.81
Estimating causal effects from epidemiological data. J Epidemiol Community Health (2006) 5.61
Adjusted survival curves with inverse probability weights. Comput Methods Programs Biomed (2004) 5.11
Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures. Stat Med (2002) 4.15
Data, design, and background knowledge in etiologic inference. Epidemiology (2001) 3.82
The role of model selection in causal inference from nonexperimental data. Am J Epidemiol (1986) 3.28
Does obesity shorten life? The importance of well-defined interventions to answer causal questions. Int J Obes (Lond) (2008) 3.18
Pillbox organizers are associated with improved adherence to HIV antiretroviral therapy and viral suppression: a marginal structural model analysis. Clin Infect Dis (2007) 3.16
Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Clin Infect Dis (2008) 3.09
Structural accelerated failure time models for survival analysis in studies with time-varying treatments. Pharmacoepidemiol Drug Saf (2005) 3.05
Sensitivity analyses for unmeasured confounding assuming a marginal structural model for repeated measures. Stat Med (2004) 2.87
Invited commentary: hypothetical interventions to define causal effects--afterthought or prerequisite? Am J Epidemiol (2005) 2.34
The effect of epoetin dose on hematocrit. Kidney Int (2007) 2.31
Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell count. Am J Epidemiol (2005) 2.20
An application of model-fitting procedures for marginal structural models. Am J Epidemiol (2005) 2.14
Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the Physicians' Health Study. Am J Epidemiol (2002) 2.02
Determining the effect of highly active antiretroviral therapy on changes in human immunodeficiency virus type 1 RNA viral load using a marginal structural left-censored mean model. Am J Epidemiol (2007) 2.00
Marginal structural models for analyzing causal effects of time-dependent treatments: an application in perinatal epidemiology. Am J Epidemiol (2004) 1.94
A practical guide to dose-response analyses and risk assessment in occupational epidemiology. Epidemiology (2004) 1.94
Assessing the effectiveness of antiretroviral adherence interventions. Using marginal structural models to replicate the findings of randomized controlled trials. J Acquir Immune Defic Syndr (2006) 1.81
On the treatment of grouped observations in life studies. Biometrics (1977) 1.76
Secondhand smoke exposure, pulmonary function, and cardiovascular mortality. Ann Epidemiol (2007) 1.76
Effects of physical activity and body composition on functional limitation in the elderly: application of the marginal structural model. Epidemiology (2004) 1.71
The effect of HIV infection on overdose mortality. AIDS (2005) 1.58
Effect of tuberculosis on the survival of women infected with human immunodeficiency virus. Am J Epidemiol (2007) 1.46
Effect of discontinuing antiretroviral therapy on survival of women initiated on highly active antiretroviral therapy. AIDS (2004) 1.18
Estimating causal treatment effects from longitudinal HIV natural history studies using marginal structural models. Biometrics (2003) 1.17
Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet (2002) 9.66
Fallibility in estimating direct effects. Int J Epidemiol (2002) 8.34
Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet (2005) 6.60
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS (2010) 5.85
Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. Am J Epidemiol (2003) 5.81
Adjusted survival curves with inverse probability weights. Comput Methods Programs Biomed (2004) 5.11
Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol (2005) 4.44
Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis. JAMA (2007) 4.40
The birth weight "paradox" uncovered? Am J Epidemiol (2006) 4.38
Coronary heart disease in postmenopausal recipients of estrogen plus progestin therapy: does the increased risk ever disappear? A randomized trial. Ann Intern Med (2010) 4.27
Epidemiology, data sharing, and the challenge of scientific replication. Epidemiology (2009) 3.49
Gout and risk of Parkinson disease: a prospective study. Neurology (2007) 3.09
Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Clin Infect Dis (2008) 3.09
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch Neurol (2003) 2.90
Sensitivity analyses for unmeasured confounding assuming a marginal structural model for repeated measures. Stat Med (2004) 2.87
Causal directed acyclic graphs and the direction of unmeasured confounding bias. Epidemiology (2008) 2.60
Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology (2008) 2.51
When to start treatment? A systematic approach to the comparison of dynamic regimes using observational data. Int J Biostat (2010) 2.50
Intervening on risk factors for coronary heart disease: an application of the parametric g-formula. Int J Epidemiol (2009) 2.48
Commentary: A structural approach to Berkson's fallacy and a guide to a history of opinions about it. Int J Epidemiol (2014) 2.23
Commentary: how to report instrumental variable analyses (suggestions welcome). Epidemiology (2013) 2.22
Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease. Am J Cardiol (2011) 2.20
Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell count. Am J Epidemiol (2005) 2.20
A Comparison of Agent-Based Models and the Parametric G-Formula for Causal Inference. Am J Epidemiol (2017) 2.05
Rates and predictors of failure of first-line antiretroviral therapy and switch to second-line ART in South Africa. J Acquir Immune Defic Syndr (2012) 2.03
Effectiveness of patient adherence groups as a model of care for stable patients on antiretroviral therapy in Khayelitsha, Cape Town, South Africa. PLoS One (2013) 2.03
Determining the effect of highly active antiretroviral therapy on changes in human immunodeficiency virus type 1 RNA viral load using a marginal structural left-censored mean model. Am J Epidemiol (2007) 2.00
We are number one but nobody cares-that's good. Epidemiology (2012) 1.97
Confounding adjustment via a semi-automated high-dimensional propensity score algorithm: an application to electronic medical records. Pharmacoepidemiol Drug Saf (2011) 1.85
Bias in observational studies of prevalent users: lessons for comparative effectiveness research from a meta-analysis of statins. Am J Epidemiol (2012) 1.76
Comparative effectiveness of dynamic treatment regimes: an application of the parametric g-formula. Stat Biosci (2011) 1.73
Apparent declining efficacy in randomized trials: examples of the Thai RV144 HIV vaccine and South African CAPRISA 004 microbicide trials. AIDS (2012) 1.71
Causal inference from longitudinal studies with baseline randomization. Int J Biostat (2008) 1.69
Estimating absolute risks in the presence of nonadherence: an application to a follow-up study with baseline randomization. Epidemiology (2010) 1.64
The parametric g-formula to estimate the effect of highly active antiretroviral therapy on incident AIDS or death. Stat Med (2012) 1.63
Long-term effects of highly active antiretroviral therapy on CD4+ cell evolution among children and adolescents infected with HIV: 5 years and counting. Clin Infect Dis (2008) 1.60
Randomized trials analyzed as observational studies. Ann Intern Med (2013) 1.60
Estimated effect of epoetin dosage on survival among elderly hemodialysis patients in the United States. Clin J Am Soc Nephrol (2009) 1.59
Infection with Chlamydia pneumoniae and risk of multiple sclerosis. Epidemiology (2003) 1.57
High doses of epoetin do not lower mortality and cardiovascular risk among elderly hemodialysis patients with diabetes. Kidney Int (2011) 1.56
Impact factor: a call to reason. Epidemiology (2009) 1.54
Observational data for comparative effectiveness research: an emulation of randomised trials of statins and primary prevention of coronary heart disease. Stat Methods Med Res (2011) 1.49
Diet and Parkinson's disease: a potential role of dairy products in men. Ann Neurol (2002) 1.46
Antibiotic use and risk of multiple sclerosis. Am J Epidemiol (2006) 1.45
Weight loss in Parkinson's disease. Ann Neurol (2003) 1.43
Weight Loss and Coronary Heart Disease: Sensitivity Analysis for Unmeasured Confounding by Undiagnosed Disease. Epidemiology (2016) 1.39
Biases in Randomized Trials: A Conversation Between Trialists and Epidemiologists. Epidemiology (2017) 1.38
Causal inference in public health. Annu Rev Public Health (2013) 1.38
Prednisone, lupus activity, and permanent organ damage. J Rheumatol (2009) 1.38
Early versus deferred antiretroviral therapy for HIV. N Engl J Med (2009) 1.35
From causal diagrams to birth weight-specific curves of infant mortality. Eur J Epidemiol (2008) 1.30
Using Big Data to Emulate a Target Trial When a Randomized Trial Is Not Available. Am J Epidemiol (2016) 1.29
Recent use of oral contraceptives and the risk of multiple sclerosis. Arch Neurol (2005) 1.27
Invited commentary: composite outcomes as an attempt to escape from selection bias and related paradoxes. Am J Epidemiol (2013) 1.27
Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries. Clin Infect Dis (2012) 1.25
Hypothetical midlife interventions in women and risk of type 2 diabetes. Epidemiology (2013) 1.23
Body mass index, diabetes, and mortality in French women: explaining away a "paradox". Epidemiology (2014) 1.22
Smoking and the risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry (2010) 1.22
Dietary intakes of fat and risk of Parkinson's disease. Am J Epidemiol (2003) 1.19
Effect modification by time-varying covariates. Am J Epidemiol (2007) 1.16
Case-only gene-environment interaction studies: when does association imply mechanistic interaction? Genet Epidemiol (2010) 1.15
Relation between three classes of structural models for the effect of a time-varying exposure on survival. Lifetime Data Anal (2009) 1.14
Statins and risk of diabetes: an analysis of electronic medical records to evaluate possible bias due to differential survival. Diabetes Care (2012) 1.12
The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study. AIDS (2012) 1.11
Survival of Parkinson's disease patients in a large prospective cohort of male health professionals. Mov Disord (2006) 1.11
Pregnancy outcomes, site of delivery, and community schisms in regions affected by the armed conflict in Chiapas, Mexico. Soc Sci Med (2005) 1.11
Obesity and the risk of Parkinson's disease. Am J Epidemiol (2004) 1.09
Counterpoint: Epidemiology to Guide Decision-Making: Moving Away From Practice-Free Research. Am J Epidemiol (2015) 1.08
Matched designs and causal diagrams. Int J Epidemiol (2013) 1.08
Changes in fish consumption in midlife and the risk of coronary heart disease in men and women. Am J Epidemiol (2013) 1.08
Selecting on treatment: a pervasive form of bias in instrumental variable analyses. Am J Epidemiol (2015) 1.07
Smoking, snuff dipping and the risk of amyotrophic lateral sclerosis--a prospective cohort study. Neuroepidemiology (2006) 1.06
Detection of pulmonary tuberculosis in Chiapas, Mexico. Ann Epidemiol (2002) 1.02
Perinatal factors and adult-onset lupus. Arthritis Rheum (2008) 1.01
Invited commentary: Agent-based models for causal inference—reweighting data and theory in epidemiology. Am J Epidemiol (2014) 1.00
Incidence of adult-onset asthma after hypothetical interventions on body mass index and physical activity: an application of the parametric g-formula. Am J Epidemiol (2013) 1.00
From counterfactuals to sufficient component causes and vice versa. Eur J Epidemiol (2006) 1.00
Case-crossover and case-time-control designs in birth defects epidemiology. Am J Epidemiol (2003) 0.98
Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis. Neurology (2006) 0.97
Folate intake and risk of Parkinson's disease. Am J Epidemiol (2004) 0.95
Association of smoking with amyotrophic lateral sclerosis risk and survival in men and women: a prospective study. BMC Neurol (2010) 0.93
β-Blocker use for patients with or at risk for coronary artery disease. JAMA (2013) 0.93
Oseltamivir effect on antibiotic-treated lower respiratory tract complications in virologically positive randomized trial participants. Clin Infect Dis (2013) 0.92
Ensemble learning of inverse probability weights for marginal structural modeling in large observational datasets. Stat Med (2014) 0.92
Beyond exchangeability: the other conditions for causal inference in medical research. Stat Methods Med Res (2012) 0.90
Think globally, act globally: An epidemiologist's perspective on instrumental variable estimation. Stat Sci (2014) 0.90
Armed conflict and poverty in Central America: the convergence of epidemiology and human rights advocacy. Epidemiology (2007) 0.89
Results on differential and dependent measurement error of the exposure and the outcome using signed directed acyclic graphs. Am J Epidemiol (2012) 0.89
A structural approach to the familial coaggregation of disorders. Epidemiology (2008) 0.88
Comparative effectiveness of two anemia management strategies for complex elderly dialysis patients. Med Care (2014) 0.87
The effect of efavirenz versus nevirapine-containing regimens in the HIV-CAUSAL Collaboration: reply to Llibre and Podzamczer and additional results. AIDS (2013) 0.87
Early life factors and adult-onset rheumatoid arthritis. J Rheumatol (2009) 0.86
Analyzing partially missing confounder information in comparative effectiveness and safety research of therapeutics. Pharmacoepidemiol Drug Saf (2012) 0.85
Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries. Clin Infect Dis (2015) 0.83
Intake of wine, beer, and spirits and the risk of clinical common cold. Am J Epidemiol (2002) 0.82
Definition and evaluation of the monotonicity condition for preference-based instruments. Epidemiology (2015) 0.82
Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis: the authors respond. Am J Kidney Dis (2007) 0.81
Major declines in epoetin dosing after prospective payment system based on dialysis facility organizational status. Am J Nephrol (2015) 0.79
Atazanavir exposure in utero and neurodevelopment in infants: a comparative safety study. AIDS (2016) 0.79